gioendothelioma of the liver: A report of two cases. Can J Gastroenterol 1993;7(7):530-534. Epithelioid hemangioendothelioma (EHE) isan uncommon tumour of endothelial origin having borderline malignant potential which frequently is initially misdiagnosed when occurring in the liver, often as cholangiocarcinoma, metastatic carcinoma or veno-occlusive disease. The authors report two cases of hepatic EHE. The fi rst case presented in a 33-year-old female and was originally misdiagnosed as cholangiocarcinoma. Only after re-evaluation of the case seven years later, because of an unexpectedly indolent clinical course, was the correct diagnosis made. The second case presented in a 26-year-old female having nonspecific gastrointestinal complaints. The diagnosis of hepatic EHE was made from a wedge biopsy of liver taken during an exploratory laparotomy. In both cases, immunohistochemical reactivity of the tumour cells for von Willebrand factor (FY1IIR:Ag) and Ulex europeaus I lectin was key to the final diagnosis. The first patient, to this time, remains asymptomatic. The second patient underwent liver transplantation and is being followed (now one year since the initial diagnosis). Hepatic EHE can present a diagnostic dilemma. The use of immunohistochemical techniques to demonstrate the vascular origin of this tumour is essential for its diagnosis. Better awareness of this lesion and the features differentiating it from other histologically similar lesions will prevent exposing affected patients to unnecessary investigations and treatments.
PITHELIOID HEMANGIOENDOTHELIoma (EHE) is an uncommon tumour of endothelial cell origin which has been reported to occur as a primary lesion in soft tissues, bone, lungs and liver (1,2). Primary hepatic EHE appears to be rare, based on the number of cases reported in the medical literature. However, because of the diagnostic difficulties it can present -as has been demonstrated by the frequency of initial misdiagnosis -it may be a more common tumour than reported (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . The etiology is uncertain. However, predisposing risk factors fo r other primary hepatic malignancies have been postulated ( 13, 14) . The clinical course of hepatic EHE is variable and unpredictable, and consensus regarding treatment has yet to be established (2,3,5, 7). However, for selected patients, liver transplantation is more frequently becoming a treatment option (4, 5) . The authors report two cases of hepatic EHE and briefly review the available literature.
CASE PRESENTATIONS
Case 1: A 33-year-old female with an unremarkable past medical history, presented with an epigastric mass and recent 6 kg weight loss. She was admitted co hospital for investigation. Laboratory data on admission were: hemoglobin, sive. Les a ureurs font etat de deux cas d'hemangio-endotheliomc epithelio'idc du foie: le premier concerne une patie nce de 33 ans chez qui l'on avait a c rronement pose initialement un diagnostic de cho la ngiocarc mome. Ce n'est qu ' . ,, . ' ,.
• ·· ' "t. , "' '. \ .. . An abdominal ultrasound revealed a large, solid, echogenic mass re placing much of the left lobe of the live r. When the patient unJerwen t a laparotomy a wedge biopsy of the left lobe ofli ver was taken. The biopsy specimen showeJ two no<lular, solid, grey-white lesions, the la rger measuring 2 cm in the greatest Jimension. H1stologically, the lesions showed prolife ra tion of predominantly epit helio id cells which had abunda nt eosmophilic cytoplasm, large nuclei with coarse c hromatin and prominent nucleoli. A t the periphery of the tumour fou, tumour cell in volve ment of adjacent sinusoids was seen wi th compression and mild disruption nf the hepatocyttL plates. Invasion of hepatic veins was promine nt. These lesions were l11S-cologically diagnosed as pnnrly di ffe rentiated cho la ngiocarcinoma ( Figure  l ). Further workup for metastases was negative.
T reatment was m itta ted with doxorubicin, 5-fluorouricil ( 5-FU ) and vincmcine. Multiple courses were given and after four years, repeated d iagnostic imaging showed the rumour had apparently regressed. I lowever, during this time, the pa tient had developed doxorubicin cardiotoxici ty (cardiomyopathy) and vincristine ne urocoxicity requ iring discontinua tion of these drugs. 5-FU was continued as a single agent for a sh ort course afterward. The c he motherapy was stopped and not restarted for two years (\~he n an asymptomattc lung lesion was identified radiogrn ph ically ). A ltho ugh a tissue d1agnos1s of this lesion was not obtained , 5-FU was resta rted for a presumed metastas is. T he che motherapy was di:scontinued after two course~ according to the patie n t's wishes. further progression of the lung a nd hep,1tic lesions was not noted a nd the parient re mained free from funher problems.
Because of the unexpectantly long, indo lent clin ical cour:;e, the originrt l J iagnosis of c.ho la ng1ocareinoma made seven yea rs earlier wa~ rev iewed. T he neoplaM ic cells exh1b1reJ reactivity for the endothelial cell ma rkers von W illebra nd fac tor antigen ( vW F:Ag) a nd Ulex europeaus I lectin ( Figure I ). Positive staining was seen within the cytoplasm, incracytoplasmic vacuoles ;i nd vascular lumina as granu lar or homogeneous deposits. A pproximately 50% of th e neoplast ic cells were reactive for each marke r. The h istological feat ures were reinte rpre ted and a rev ised Jiagnosis of hepatic EHE was made. To this time, now 10 years smce first presenting to her physician, the patie nt remains asymp1 o mat1c.
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• The patient underwent an exploratory laparotomy during which a wedge biopsy of li ver was taken. T he biopsy showed several grey-white, solid masses ( the largest measured 2 cm in greatest dimension). Histologically (Figure 2) , the lesions showed fea tures similar to those in case 1 except that most cells were singly dispersed. There was intravascular and intrasinsoidal invasion and/or embolization and a mixed inflammatory infiltrate, including foreign body-type granulomas. Approximately 60% of the neoplastic cells exhibited reactivity of bo th vWF:Ag and Ulex europeaus I lectin. The diagnosis of hepatic EHE was made.
The patient underwent successful liver transplantation one year ago and currently is being followed. At this time, now two years since first presenting, there is no evidence of extrahepatic dissemination .
DISCUSSION
EHE is an uncommo n tumour of endothelial cell oligin. Weiss and Enzinger ( 1) suggested the name after studying the soft tissue counterpart of the lesion, the intravascular bronchiolalveolar tumour o riginally described in the lung which was later shown co have a vascular histogenesis (1 ). Based on the epithelioid-appearing tumour cells, a pattern of solid growth and a clinical course intermediate between hemangioma and angiosarcoma, they suggested the new name, EHE. Other names have been proposed including sclerosing endo thelial tumour, sclerosing angiogenic tumour and sclerosing epithelioid angiosarcoma (2) .
Fewer than 100 case of primary hepatic EHEs have been reported in the medical literature (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . The patients ranged in age from 12 co 86 years ( mean 41.5) with a female: malc ratio of 2: 1. The most frequent signs and symptoms at presentation included right upper quadrant pain or discomfort, hepatomegaly, jaundice, fever, anorexia, weight loss and ascites. Laboratory data at presentation were rather nonspecific, but alkaline phosphatase was frequently elevated. Alpha-fecoprotein and CEA levels were normal. Most lesions were multiple and ranged in size from 0.5 to 12 cm. Approximately 40% of patients had, at some point, mediastatic ex trahepatic tumour. The most common sites of metastases were lung, abdominal lymph nodes, peritoneum, spleen and medias tinum. Survival was extremely variable, ranging from months to 28 years from initial diagnosis. However, in many patients the rumour showed unusually slow progressio n, a feature of this lesion.
T o diagnose an hepatic EHE can be difficult. The clinical features are nonspecific and laboratory investigations are most useful in identifying general hepatic injury and in aiding the exclusion of some ocher lesions. Radiographically, the entity can present as nodular or diffuse lesions, the diffuse form probably resulting from coalescence of multiple nodules and representing a more advanced form of disease (7,8). The radiographic appearance of nodular hepatic EHE is similar to that of some hepatic metastases, making differentiation difficult. However, certain combined rad iological findings have been suggested as being useful in the identification of the diffuse form; these are moderately increased tumour vascularity spreading predominantly along the outside edge of both hepatic lobes, hypovascular areas within the tumour, intratumoural calcification , enlargement of the uninvolved hepatic parenchyma with resulting deformity of hepatic contour and abse nce of some intrahepatic po rtal branch es sho wn angiographically (7).
Histologically, the neoplasm has features which can present <liagnostic difficulty. The neoplastic cells have denJritic or epirhel ioid appearance and are seen infiltrating sinusoi<ls and veins, dispersed within a variable but often abundant stroma that may have myxoid, sclerotic or calcifying features. Microscopic evidence of vascu lar Jifferentiation may be seen in the form of variably sized intracytoplasmic vacuoles and in well -defined structures lined by neoplastic cells an<l containing red blood cells within central lumina (4, 10) . The presence of den<lritic cells signifying mesenchymal origin, the involvement of branches of hepatic and portal veins and the infiltrative nature of growth (but with peripheral preservation of hepatic acinar structure) help to differentiate hepatic EHE from cholangiocarcinoma and hepatocellular carcinoma. Negative staining for mucin and bile, negative immunochemical staining for CEA and alpha-fetoprotein and the presence of many thin filaments and Weibel-Palade bodies, ultrastructurally, are other useful differentiating features (2, 10) . However, for practical purposes, it is the identification of the tumour cells' vascular origin, based on their immunohistochemical reacttv1ty for vWF:Ag and Ulex europeaus I leccin, that is key to the correct diagnosis (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Positive staining of the neoplastic cells tends to be variable and may be seen within the cytoplasm, intracytoplasmic vacuoles and/or within vascular lumina. Generally, the epithelioic.l cells stain for these endothelial markers more frequently an<l intensely than dendritic tumour cells. Furthermore, as the stromal component becomes more prominent, the number of positi ve cells a nd intensity of the staining reactions becomes less (12) .
More recently, a new monoclonal antibody to endothelium (QBEND/10) has been reporce<l to be superior to vWF:Ag and Ulex europeaus I lectin in identifying the characteristic intracytoplasmic lumina in El IE. It was founJ to be more sensitive than vWF:Ag and specific than Ulex europeaus l lectin for endothelium. Furthermore, QBEND/10 tended to stain the background stroma less than the ocher two markers, thereby a llowing better visualization of cytoplasmic vacuoles and lumina (15) .
Hepatic EHE may histologically resemble other vascu lar tumours, such as angiosarcoma. Criteria that are useful in the d ifferentiation and point towards angiosarcoma include variable growth along hepatic plates, the presence of an interanastomizing pattern on reticular stains, anaplastic cytological features and the presence of mitotic figures (5). Hepatic EHE has also been confused for post necrotic fibrosis and veno-occlusive disease since, in certain cases, the histological appearance can make even the recognition of a neoplastic process being present difficult (11 ). It is the iJentification of dendritic anJ/or epithelioi<l cells positive fo r endothelial cell markers and which have an invasive growth pattern which points towards a neoplastic lesion of vascular of liver transplantation. origin (ie, EHE), even if cel lular atypia is relatively mild. ln our first case, the rumour was initially mis<liagnosed as cholangiocarcinoma. Only later, after an unexpecccJly in<lolent clinical course, was there reevaluation of the lesion and the correct Jiagnosis made. The histological cvi<lence of vascu lar c.liffcrentiation was originally misinterprete<l. It was not until the tumour cells were idenrificc.l as being of endothelial cell origin, based on reactivity for vWF:Ag and Ulex euro/)eaus I lectin, was the correct diagnosis made. Likewbe, recognition of the derivation of neoplastic cells in the second case using immunohiscochemical techniques, in conjunction with the clinical, radiological anJ other histological findings, was required to establish the correct d iagnosis.
Although in our cases wedge biopsies were obtained for pathological diagnosis, needle biopsy may be a<lequate for diagnosis, providing the tumour has been a<lequatcly sampled an<l immunohistochemical techniques for iJentification of its vascular origin are used. At least one diagnosis of an hepatic EHE based on fine-needle aspiration cytology has been reported (16) .
In conclusion, we hope to Jraw fu rther awareness to this lesion anJ the Jiagnostic difficulties it can present. Misdiagnosis of this lesion can leac.l to unnecessary investigations and treatments. The use of immunohistochemical techniques for the i<lentification of endothelial cell Jerivation often is essential for the correct diagnosis of EHE.
